Altium Capital is a Healthcare Investment Fund Founded by Jacob Gottlieb in 2018
Altium Capital is a New York City-based investment fund founded by Jacob Gottlieb. The fund focuses on healthcare investments, especially innovative companies with an aim of making significant advances in medical treatments. The hedge fund has invested in companies that provide progressive therapies, including the following:
- Oramed Pharmaceuticals: With support from industry-leading experts in the science field, this Manhattan-based company created an oral alternative to injectables for diabetics.
- Amarin: Focused on cardiovascular health, the Dublin, Ireland-based Amarin developed a prescription-grade omega-3 fatty acid approved by the FDA in 2012.
- Oragenics: This Tampa firm produces antibiotics that replace bad bacteria with good. The company is able to develop antibiotics at an impressively speedy rate because of its collaboration with Intrexon Corporation, Inc.
It isn’t surprising that these growth companies would appeal to seasoned investors with extensive experience in the healthcare sector. The potential for exponential growth in an industry in which Gottlieb has already achieved dramatic success makes them attractive choices.
With help from Gottlieb’s educational background in biochemistry, investment savvy and leadership skills, Altium Capital shows tremendous potential. Industry professionals and long-term casual investors alike will be watching what happens at Altium Capital. Jacob Gottlieb has taken his companies to staggering heights in the past, and anticipation is growing as news of Altium Capital spreads.